Innovation seems like all fun and games, but the reality is a grind. We salute the health entrepreneurs who attend...
Read moreMarketing in healthcare has always been murky. For healthcare startups, it is downright dangerous, as it is where many Department...
Read moreThese apps, websites and services are there to help students, young adults and adults overcome challenges with stress, anxiety, substance...
Read moreElon Musk purchased Twitter. The political world is now ablaze. But there is another world that should be just as...
Read moreGrowth for successful healthcare startups is defined financially. In reality, growth should be defined by clinical improvements, which is less...
Read moreThe first end-to-end human genome was officially published on Mar. 31, 2022.
Read morePortable air filters are an option for augmenting ventilation systems, but they typically cost hundreds of dollars, which puts them...
Read moreDelta-8 THC is a hemp-derived compound that’s closely related to delta-9 THC – what’s commonly called THC and is the...
Read moreHealthcare innovators assume patients trust healthcare technology. But trust in technology wanes when patients lose autonomy. So instead of trust,...
Read moreThe perceptions of healthcare entrepreneurship differ from its realities. This is why many healthcare startups fail.
Read moreThe FDA recently approved a drug touted to treat Alzheimer's Disease. A decision decried by policy experts as data supporting...
Read moreOne Medical acquired Iora Health, a surprising integration of two vastly different companies that does not make sense at first...
Read moreClinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy